Related Experiment Video
Updated: Feb 23, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
[Tumour sequencing: Evolutions and revolutions]
N Piton1, A Lamy1, J-C Sabourin1
1Service de pathologie, hôpital Charles-Nicolle, Normandie université, CHU de Rouen, 1, rue de Germont, 76031 Rouen, France; Inserm U1245, 1, rue de Germont, 76000 Rouen, France.
Genomic analysis of tumors, or tumor genotyping, is revolutionizing cancer care by guiding therapy choices and improving diagnosis. The main challenge now lies in interpreting these genetic findings for better patient outcomes.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- The genomic era has transformed cancer care, enabling detailed tumor genotyping.
- Technological advancements facilitate genomic analysis in clinical settings, impacting patient management.
Purpose of the Study:
- To highlight the advancements and challenges in tumor genotyping for clinical applications.
- To emphasize the shift from detecting molecular alterations to interpreting their clinical significance.
Main Methods:
- Genomic analysis of formalin-fixed paraffin-embedded tissues.
- Emerging techniques like liquid biopsies for cancer genotyping.
- Routine gene panel genotyping using high-throughput sequencing.
Main Results:
- Tumor genotyping significantly influences therapeutic decisions, diagnosis, and disease monitoring.
- High-throughput sequencing enables routine genotyping for specific cancer types.
- Liquid biopsies offer a promising alternative for genomic analysis.
Conclusions:
- Tumor genotyping is increasingly integrated into routine medical practice.
- The primary challenge in cancer genomics has evolved to the interpretation of molecular alterations.
- Accurate interpretation of genetic data is crucial for optimizing patient care and treatment strategies.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...

